Loic Ysebaert

19PUBLICATIONS
120CO-AUTHORS
Tumour immunologyHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 02, 2026
3D ex vivo platform for high-throughput immunotherapy screening in relapsed/refractory lymphoma patients.

|Jun 23, 2026
Comparative atrial fibrillation risk across Bruton's tyrosine kinase inhibitors in B-cell malignancies: A nationwide population-based study.

|Apr 26, 2025
Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non-Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group.

Charles Herbaux, Emmanuel Bachy, Reda Bouabdallah

|Jan 22, 2025
Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.

Sarka Pavlova, Jitka Malcikova, Lenka Radova

|Jul 22, 2024
New pharmacodynamic parameters linked with ibrutinib responses in chronic lymphocytic leukemia: Prospective study in real-world patients and mathematical modeling.

Sarah Cadot, Chloe Audebert, Charlotte Dion

|Feb 16, 2024
Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial.

Vincent Camus, Catherine Thieblemont, Philippe Gaulard

Pageof 4

Frequent Collaborators

3 joint publications

Franck Morschhauser

3 joint publications

Emmanuel Bachy

3 joint publications

René-Olivier Casasnovas

2 joint publications

Virginie Nerich